backed by a growing Network of more than 130 trusted partners, customers, and supporting organizations
Injection device
Love Lifesciences is committed to reshaping the future of injectables in the compounding market. Our flagship innovation, UNIPEN, is the first therapeutic-agnostic injection system designed to optimize efficiency, safety, and precision across a diverse range of therapies.
Whether you’re compounding medications for personalized care or delivering life-enhancing treatments, UNIPEN elevates every step of the injectable experience.
how to use unipen®
LAUNCHING WITH UNIPEN®
A Platform Meeting Industry Quality and Manufacturing Standards, Designed for the Compounding Pharmacy Market
The UNIPEN Platform is an integrated device deployment program aligned with pharmaceutical industry standards.
UNIPEN provides compounding pharmacies a streamlined pathway to launching sterile injectable products in a patient-centric device.
By minimizing timelines and upfront costs, UNIPEN offers compounding pharmacies enhanced patient satisfaction outcomes and financial benefits previously only available to pharmaceutical companies.
Core Team
Our team is dedicated to revolutionizing the patient injection experience for those requiring chronic injection therapeutics.
Nick Love, MD, MBA
CEO & Co-Founder
Background in Biopharma business analytics & research
Board Member – BioKansas
Advisory Board – KU School of Medicine
Bradley Hopper
CTO & Co-Founder
10y+ founding & growing companies in various industries
Background in Product Design & Engineering
Erik Blume, JD, MBA
Chief operating officer
10y+ working with bioscience and tech startups
Licensed attorney
Board Member – Bio Kansas
Richard Hollocher
Lead Engineer
Experienced mechanical engineer with a background at Honeywell and Spirit Aerosystems
Sujal Shah
Head of Growth Strategy
20y+ in MedTech commercial & market development strategy leadership for Johnson & Johnson, Pfizer
John Ziobro
Head of Regulatory Affairs
35y+ Medical Device expertise including executive management, engineering, regulatory affairs
CONTACT US